242 related articles for article (PubMed ID: 29172946)
1. Postprandial gut microbiota-driven choline metabolism links dietary cues to adipose tissue dysfunction.
Schugar RC; Willard B; Wang Z; Brown JM
Adipocyte; 2018 Jan; 7(1):49-56. PubMed ID: 29172946
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
[TBL] [Abstract][Full Text] [Related]
3. Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.
Anwar S; Bhandari U; Panda BP; Dubey K; Khan W; Ahmad S
J Pharm Biomed Anal; 2018 Sep; 159():100-112. PubMed ID: 29980011
[TBL] [Abstract][Full Text] [Related]
4. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
Massey W; Brown JM
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Microbiome in Heart Failure.
Kitai T; Kirsop J; Tang WH
Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial.
Heianza Y; Sun D; Li X; DiDonato JA; Bray GA; Sacks FM; Qi L
Gut; 2019 Feb; 68(2):263-270. PubMed ID: 29860242
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
8. The gut microbiome, diet, and links to cardiometabolic and chronic disorders.
Aron-Wisnewsky J; Clément K
Nat Rev Nephrol; 2016 Mar; 12(3):169-81. PubMed ID: 26616538
[TBL] [Abstract][Full Text] [Related]
9. Microbiome, trimethylamine N-oxide, and cardiometabolic disease.
Tang WH; Hazen SL
Transl Res; 2017 Jan; 179():108-115. PubMed ID: 27490453
[TBL] [Abstract][Full Text] [Related]
10. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
[TBL] [Abstract][Full Text] [Related]
11. A review of the relationship between the gut microbiota and amino acid metabolism.
Lin R; Liu W; Piao M; Zhu H
Amino Acids; 2017 Dec; 49(12):2083-2090. PubMed ID: 28932911
[TBL] [Abstract][Full Text] [Related]
12. Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications.
Leustean AM; Ciocoiu M; Sava A; Costea CF; Floria M; Tarniceriu CC; Tanase DM
J Diabetes Res; 2018; 2018():5205126. PubMed ID: 30539026
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota in Adipose Tissue Dysfunction Induced Cardiovascular Disease: Role as a Metabolic Organ.
Yang X; Zhang X; Yang W; Yu H; He Q; Xu H; Li S; Shang Z; Gao X; Wang Y; Tong Q
Front Endocrinol (Lausanne); 2021; 12():749125. PubMed ID: 34552566
[TBL] [Abstract][Full Text] [Related]
15. Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms.
Schugar RC; Gliniak CM; Osborn LJ; Massey W; Sangwan N; Horak A; Banerjee R; Orabi D; Helsley RN; Brown AL; Burrows A; Finney C; Fung KK; Allen FM; Ferguson D; Gromovsky AD; Neumann C; Cook K; McMillan A; Buffa JA; Anderson JT; Mehrabian M; Goudarzi M; Willard B; Mak TD; Armstrong AR; Swanson G; Keshavarzian A; Garcia-Garcia JC; Wang Z; Lusis AJ; Hazen SL; Brown JM
Elife; 2022 Jan; 11():. PubMed ID: 35072627
[TBL] [Abstract][Full Text] [Related]
16. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity.
Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y
Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145
[TBL] [Abstract][Full Text] [Related]
17. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota in Vascular Disease: Therapeutic Target?
Anbazhagan AN; Priyamvada S; Priyadarshini M
Curr Vasc Pharmacol; 2017; 15(4):291-295. PubMed ID: 28056754
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?
Chaikijurajai T; Tang WHW
Curr Heart Fail Rep; 2021 Apr; 18(2):23-32. PubMed ID: 33559845
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of intestinal microbiota and microbial metabolites in metabolic control.
Herrema H; IJzerman RG; Nieuwdorp M
Diabetologia; 2017 Apr; 60(4):613-617. PubMed ID: 28013341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
